Next Article in Journal
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Previous Article in Journal
Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(19), 4932; https://doi.org/10.3390/cancers14194932
Action Date Notes Link
article xml file uploaded 8 October 2022 14:32 CEST Original file -
article xml uploaded. 8 October 2022 14:32 CEST Update -
article pdf uploaded. 8 October 2022 14:32 CEST Version of Record -
article html file updated 8 October 2022 14:34 CEST Original file -
article xml file uploaded 8 October 2022 15:01 CEST Update -
article xml uploaded. 8 October 2022 15:01 CEST Update https://www.mdpi.com/2072-6694/14/19/4932/xml
article pdf uploaded. 8 October 2022 15:01 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4932/pdf
article html file updated 8 October 2022 15:02 CEST Update -
article html file updated 28 February 2023 17:08 CET Update -
article html file updated 1 March 2023 20:11 CET Update https://www.mdpi.com/2072-6694/14/19/4932/html
Back to TopTop